In addition, the FDA approved NextAR’s shoulder application, and cleared the system’s knee application last year.
NextAR is designed to improve surgical accuracy and reduce the cost per case by eliminating robotic arms or other OR equipment operators that require a lot of space in the operating room, according to the company.
The system includes artificial intelligence and machine learning tools to improve preoperative planning.
“We wanted to take another step forward in personalized medicine, improving accuracy in computer-assisted surgery,” Medacta CEO Francesco Siccardi said in a May 27 news release. “We are proud to have developed an extremely versatile platform, with a single, compact hardware that applies to both joint and spine applications.”
Medacta said the technology is ideal for ASCs as it requires less OR space, has a low upfront capital investment and lower cost per case compared to other surgical technologies.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
